New research from the U-M Medical School may explain why common antioxidant treatments have failed against inflammatory bowel disease. Led by Dr. Yatrik Shah, the team identified a link between a specific type of cell death and chronic gut inflammation. Using patient samples, they explored a more targeted approach—one that could lead to more effective therapies for Crohn’s and colitis.
We use cookies to ensure you get the best experience on our website. By using this site, you accept our use of cookies.